Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2025-12-24 @ 6:36 PM
NCT ID:
NCT00746057
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 to 65 years old,
* Donor's age ≤ 60 years old,
* Patients receiving a first cadaveric renal graft,
* Patients taking immunosuppressant treatment including an induction with Simulect at day 0 and day 4, FK 506 (Prograf®) associated with Cellcept and steroids (for three months),
* Patients don't taking indispensable anticoagulant treatment.
Exclusion Criteria:
* Patient's age \< 18 or \> 65 years old,
* Donor's age ≥ 60 years old,
* Pregnant women or breast feeding women,
* Patients receiving a retransplantation, a kidney and pancreas graft or a graft from a living donor,
* Patients taking immunosuppressant treatment without FK 506 (Prograf®), Cellcept and steroids.
* Patients with coagulation troubles or taking indispensable anticoagulant treatment,
* No biopsy before graft.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00746057
Study Brief:
Protocol Section:
NCT00746057